Destruction of articular cartilage is a common feature of the final pathway in arthritides such as rheumatoid arthritis (RA) and osteoarthritis (OA). This process is thought to be controlled largely by cytokines released from the synovium or the cartilage matrix itself under the influence of various noxious stimuli. Interleukin-1(IL-1) produced by joint tissues is a major inducer of matrix metalloprotease (MMP) gene expression in chondrocytes and synoviocytes. The binding of IL-1 to its receptor (IL-IR) is an obligatory step resulting in elicitation of signal transduction and to MMP up-regulation. This developmental and feasibility project will test the hypothesis that free forms of interleukin-1 receptor (IL-IR) obtained from chondrocytes or a receptor fragment obtained by enzymatic cleavage may be useful as reagents to antagonize IL-1 binding to IL-IR. Two approaches to produce receptor will be used in these studies: 1.) chondrocytes will be grown in culture, membranes solubilized with detergent, and the soluble receptor (dsIL-IR) purified by affinity chromatography on immobilized antibodies to human T-lymphocytic cell-line IL-IR (type 1). Further purification will be achieved by chromatography on immobilized conconavalin-A. Purified dsil-IR will be identified by SDS- polyacrylamide gel electrophoresis followed by transfer to membranes and probing with 125I-labeled IL-1beta. 2) A second approach will aim to produce a recombinant IL-IR) by expression cloning of the extracellular portion of chondrocyte IL-IR. Proteolytic fragments of receptor (IL- IRFs) will be generated by enzymatic digestion with various proteolytic enzymes and purified by High Liquid Chromatography (HPLC). IL-IR and IL- IRFs will be tested in vitro for ability to block IL-1 binding to its receptor. Rabbit-derived IL-IR and fragments thereof will be tested in the rabbit partial meniscectomy OA model to assess the efficacy of the preparations in vivo.

Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Case Western Reserve University
United States
Zip Code
Miwa, Hazuki E; Gerken, Thomas A; Huynh, Tru D et al. (2009) Conserved sequence in the aggrecan interglobular domain modulates cleavage by ADAMTS-4 and ADAMTS-5. Biochim Biophys Acta 1790:161-72
Atif, U; Philip, A; Aponte, J et al. (2008) Absence of association of asporin polymorphisms and osteoarthritis susceptibility in US Caucasians. Osteoarthritis Cartilage 16:1174-7
Kraus, V B; Jordan, J M; Doherty, M et al. (2007) The Genetics of Generalized Osteoarthritis (GOGO) study: study design and evaluation of osteoarthritis phenotypes. Osteoarthritis Cartilage 15:120-7
Miwa, Hazuki E; Gerken, Thomas A; Huynh, Tru D et al. (2006) Mammalian expression of full-length bovine aggrecan and link protein: formation of recombinant proteoglycan aggregates and analysis of proteolytic cleavage by ADAMTS-4 and MMP-13. Biochim Biophys Acta 1760:472-86
Holderbaum, D; Malvitz, T; Ciesielski, C J et al. (2005) A newly described hereditary cartilage debonding syndrome. Arthritis Rheum 52:3300-4
Denko, Charles W; Malemud, Charles J (2005) Role of the growth hormone/insulin-like growth factor-1 paracrine axis in rheumatic diseases. Semin Arthritis Rheum 35:24-34
Ievers-Landis, Carolyn E; Burant, Christopher; Drotar, Dennis et al. (2005) A randomized controlled trial for the primary prevention of osteoporosis among preadolescent girl scouts: 1-year outcomes of a behavioral program. J Pediatr Psychol 30:155-65
Vashishth, D (2005) Collagen glycation and its role in fracture properties of bone. J Musculoskelet Neuronal Interact 5:316
Denko, Charles W; Malemud, Charles J (2005) Serum growth hormone and insulin but not insulin-like growth factor-1 levels are elevated in patients with fibromyalgia syndrome. Rheumatol Int 25:146-51
Denko, Charles W; Malemud, Charles J (2004) Age-related changes in serum growth hormone, insulin-like growth factor-1 and somatostatin in system lupus erythematosus. BMC Musculoskelet Disord 5:37

Showing the most recent 10 out of 92 publications